Triamcinolone Acetonide Aqueous Nasal Spray: Safe and Effective in Young Children
Robin Drucker
Abstract
Robin Drucker
Abstract
Allergic rhinitis affects up to 42% of children by age 6 years, but few studies have evaluated the effects of intranasal corticosteroids in children aged 2 to 5 years. To address concerns that intranasal corticosteroids may affect the hypothalamic-pituitary axis and growth of young children, researchers conducted a manufacturer-funded, randomized, double-blind, placebo-controlled study of triamcinolone acetonide aqueous nasal spray (TAA AQ) in children aged 2 to 5 years who had allergic rhinitis. Children with symptoms of allergic rhinitis for at least 1 …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Allergic rhinitis affects up to 42% of children by age 6 years, but few studies have evaluated the effects of intranasal corticosteroids in children aged 2 to 5 years. To address concerns that intranasal corticosteroids may affect the hypothalamic-pituitary axis and growth of young children, researchers conducted a manufacturer-funded, randomized, double-blind, placebo-controlled study of triamcinolone acetonide aqueous nasal spray (TAA AQ) in children aged 2 to 5 years who had allergic rhinitis. Children with symptoms of allergic rhinitis for at least 1 …
Key concepts: Triamcinolone acetonide, Medicine, Nasal spray, Nasal administration, Placebo, Corticosteroid, Anesthesia, Pediatrics